Soluble guanylate cyclase activators

Details for Australian Patent Application No. 2010218224 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Kim, Ronald M.; Parmee, Emma R.; Sinz, Christopher Joseph; Ziouzina, Olga A.

Agent Spruson & Ferguson

Pub. Number AU-A-2010218224

PCT Pub. Number WO2010/099054

Priority 61/208,648 26.02.09 US

Filing date 22 February 2010

Wipo publication date 2 September 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/099054 Priority application(s): WO2010/099054

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010218229-Hinged fiber optic module housing and module

2010218209-Indole derivatives as CRTH2 receptor antagonists